ValiRx Plc - VAL201 Clinical Trial Full Data Results
VAL Mon, 30 Nov 2020, 03:30pm GMT
ValiRx Plc is a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines towards commercialisation and partnering
Industry: Health Care
Dr Suzy Dilly, Chief Executive Officer discusses the VAL201 clinical trial results. The full dataset confirms VAL201 is a safe and well-tolerated drug candidate, demonstrating the potential of VAL201 for further development towards a treatment for patients with prostate cancer.